Price movement over the last 24 hours
Bank Amar Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Amar Indonesia Tbk trades at Rp204 (market cap 3.82T, 683.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Bank Amar Indonesia Tbk is far larger — about 23.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 683.3K). Which is the better fit depends on your goals.
| AMAR | OBAT | |
|---|---|---|
Market Cap | 3.82T | 160.57B |
Volume | 683.3K | 2.51M |
Lot | 6.83K | 25.09K |
Turnover | 137.49M | 636.74M |
Average Price | 201.22 | 253.78 |
Value | 137.49M | 636.74M |
Indicative Equilibrium Price | 204 | 242 |
Indicative Equilibrium Volume | 500 | 146 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Amar Indonesia Tbk (the "Bank"), formerly PT Anglomas International Bank, was established in 1991 based on Deed No. 32 dated March 15, 1991 of Eddy Widjaja, S.H., notary in Surabaya.
Read more on AMAR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →